Biotech · Private company · Waltham, MA, US
Checkpoint Therapeutics, Inc.
SEC CIK 0001651407
Track this companyFree. Adds Checkpoint Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- CK-101Phase 1 · Lung NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyPHASE4 · RECRUITING · started Apr 23, 2026ClinicalTrials.gov NCT07426484 · fetched Nov 12, 2026
- Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 1, 2016ClinicalTrials.gov NCT02926768 · fetched Nov 12, 2026
SEC filings11
- 8-K · FORM 8-KSEC EDGAR · filed May 30, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 29, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 22, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 13, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2025 · fetched Nov 12, 2026
- 8-K · FROM 8-KSEC EDGAR · filed Apr 15, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 28, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 28, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 10, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jan 10, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Dec 16, 2024 · fetched Nov 12, 2026